Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Pragmatic Randomized, Double-blind, Placebo-controlled Trial of Xuezhikang Capsule for Treating Dyslipidemia: a Postmarketing Study

NCT02057302 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT02057302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02057302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Pragmatic Randomized, Double-blind, Placebo-controlled Trial of Xuezhikang Capsule for Treating Dyslipidemia: a Postmarketing Study
Lead sponsor
China Academy of Chinese Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
Not reported
Enrollment
2,400 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia